Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment

Pediatrics

Volumn 99, Issue 5, 1997, Pages 655-659

  Simons, F Estelle R ^a,b   Gerstner, Thomas V ^a   Cheang, Mary S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE   (Canada)

Author keywords

beclomethasone dipropionate; exercise induced asthma; inhaled glucocorticoid; salmeterol; 2 adrenergic agonist

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; LONG ACTING DRUG; PLACEBO; PSEUDOEPHEDRINE; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERANCE; EXERCISE INDUCED ASTHMA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; METERED DOSE INHALER; NEBULIZER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030895074     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.99.5.655     Document Type: Article

References (30)

1. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child. 1992;67:1014-1017
2. Newnham DM, Ingram CG, Earnshaw J, Palmer JBD, Dhillon DP. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma. Respir Med. 1993;87:439-444
3. Sichletidis L, Daskalopoulou E, Kyriazis G, et al. Comparative efficacy of salbutamol and salmeterol in exercise-induced asthma. J Int Med Res. 1993;21:81-88
4. Kemp JP, Dockhorn RJ, Busse WW, Bleecker ER, Van As A. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am J Respir Crit Care Med. 1994;150:1612-1615
5. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med. 1994;88:363-368
6. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992;146:1559-1564
7. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136:225-244
8. Henriksen JM, Agertoft L, Pedersen S. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children. J Allergy Clin Immunol. 1992;89:1176-1182
9. Kraemer R, Sennhauser F, Reinhardt M. Effects of regular inhalation of beclomethasone dipropionate and sodium cromoglycate on bronchial hyperreactivity in asthmatic children. Acta Paediatr Scan . 1987;76: 119-123
10. Freezer NJ, Croasdell H, Doull IJM, Holgate ST. Effect of regular inhaled beclomethasone on exercise and methacholine airway responses in school children with recurrent wheeze. Eur Respir J. 1995;8:1488-1493
11. Godfrey S, Bar-Yishay E. Exercised-induced asthma revisited. Respir Med. 1993;87:331-344
12. McFadden ER Jr, Gilbert IA. Exercise-induced asthma. N Engl J Med. 1994;330:1362-1367
13. Rossing TH, Weiss JW, Breslin FJ, Ingram RH Jr, McFadden ER Jr. Effects of inhaled sympathomimetics on obstructive response to respiratory heat loss. J Appl Physiol. 1982;52:1119-1123
14. Latimer KM, O'Byrne PM, Morris MM, Roberts R, Hargreave FE. Bronchoconstriction stimulated by airway cooling. Better protection with combined inhalation of terbutaline sulphate and cromolyn sodium than with either alone. Am Rev Respir Dis. 1983;128:440-443
15. Mussaffi H, Springer C, Godfrey S. Increased bronchial responsiveness to exercise and histamine after allergen challenge in children with asthma. J Allergy Clin Immunol. 1986;77:48-52
16. Roger LJ, Kehrl HR, Hazucha M, Horstman DH. Bronchoconstriction in asthmatics exposed to sulfur dioxide during repeated exercise. J Appl Physiol. 1985;59:784-791
17. Simons FER, Soni NR, Watson WTA, Becker AB. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma. J Allergy Clin Immunol. 1992;90:840-846
18. Verberne AAPH, Hop WCJ, Bos AB, Kerrebijn KF. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children. J Allergy Clin Immunol. 1993;91:127-134
19. Russell G, Williams DAJ, Weller P, Price JF. Salmeterol xinafoate in children on high dose inhaled steroids. Ann Allergy Asthma Immunol. 1995;75:423-428
20. Cockcroft DW, Swystun VA, Bhagat R, Kalra S. Salmeterol and airway response to allergen. Can Respir J. 1997;4:37-40
21. Giannini D, Carletti A, Dente FL, et al. Tolerance to salmeterol in allergen induced bronchoconstriction. Am J Respir Crit Care Med. 1995; 151:A39
22. Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ. Long-term effects of a long-acting β-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med. 1992;327:1198-1203
23. Milot J, Boulet L-P, Laviolette M, Côté J, Malo J-L, Cartier A. Tolerance to the salmeterol protective effects on methacholine-induced bronchoconstriction and influence of inhaled corticosteroids. Am J Respir Crit Care Med. 1996;158:A. #804
24. Verberne AAPH, Hop WCJ, Creyghton FBM, et al. Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma. J Allergy Clin Immunol. 1996;97:938-946
25. Meijer GG, Postma DS, Mulder PGH, Van Aalderen WMC. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids. Am J Respir Crit Care Med. 1995;152:1887-1892
26. Kalra S, Swystun VA, Bhagat R, Cockcroft DW. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest. 1996;109:953-956
27. 2 agonist salmeterol in mild to moderate asthmatic patients. Thorax. 1993;48:1121-1124
28. Simons FER and co-investigators. A one-year placebo-controlled study of the efficacy and safety of beclomethasone dipropionate versus salmeterol xinofoate in glucocorticoid-naive children with asthma. J Allergy Clin Immunol. 1997;99:S402
29. 2-agonist therapy: vox clamantis in deserto vel lux in tenebris? J Allergy Clin Immunol. 1995;95:641-651
30. Banned Substance Update. Canadian Centre for Drug-Free Sport Advisory Note, March 12, 1996